AGARWAL SUNIL

CIK 00016166407 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001616640

Recent Transactions

48 trades

Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2024-05-29+9,070→ 9,070 total
Award
ARVINAS, INC.$ARVN
Common Stock
2024-05-29+5,899→ 14,141 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2024-04-08+28,200→ 28,200 total
Award
ARVINAS, INC.$ARVN
Common Stock
2023-06-15+8,242→ 8,242 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2023-06-15+24,948→ 24,948 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2022-06-01+20,000→ 20,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Options (Right to Buy)
2022-03-03+250,000→ 250,000 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2021-09-16$26.00/sh−1,627→ 1,550,000 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2021-09-15$26.07/sh−58,373→ 1,551,627 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2021-06-11+20,000→ 20,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2021-02-03+48,000→ 48,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2021-02-03+76,682→ 76,682 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−3,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−6,600→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Disposition from Tender
MyoKardia, Inc.
Common Stock
2020-11-17−4,100→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−22,000→ 0 total
Award
MyoKardia, Inc.
Restricted Stock Units
2020-06-18+1,800→ 1,800 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2020-06-18+3,000→ 3,000 total
Exercise/Conversion
MyoKardia, Inc.
Common Stock
2020-06-13+2,300→ 2,300 total
Exercise/Conversion
MyoKardia, Inc.
Restricted Stock Units
2020-06-13−2,300→ 0 total
Exercise/Conversion
MyoKardia, Inc.
Common Stock
2020-06-13+2,300→ 2,300 total
Exercise/Conversion
MyoKardia, Inc.
Restricted Stock Units
2020-06-13+2,300→ 0 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2020-06-09+20,000→ 20,000 total
Award
MyoKardia, Inc.
Restricted Stock Units
2019-06-13+2,300→ 2,300 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2019-06-13+6,600→ 6,600 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2019-05-30+11,000→ 11,000 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2018-06-12+11,000→ 11,000 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2018-05-31+11,000→ 11,000 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−84,549→ 65,028 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−29,135→ 35,893 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−35,893→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−313,797→ 0 total
Award
Juno Therapeutics, Inc.
Common Stock
2018-01-31+29,135→ 149,577 total
Award
Juno Therapeutics, Inc.
Common Stock
2017-10-20+35,893→ 120,442 total
Sale
Juno Therapeutics, Inc.
Common Stock
2017-10-02$44.76/sh−7,285→ 84,549 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2017-06-14+11,000→ 11,000 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2017-06-09+11,000→ 11,000 total
Award
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2017-04-13+313,797→ 313,797 total
Award
Juno Therapeutics, Inc.
Common Stock
2017-04-13+96,627→ 96,627 total
Tax Payment
Juno Therapeutics, Inc.
Common Stock
2017-04-13$24.01/sh−4,793→ 91,834 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2016-06-20$54.16/sh−650→ 10,569 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2016-06-19$54.99/sh−392→ 11,219 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2016-05-24$66.00/sh−650→ 7,111 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2014-08-19+25,000→ 25,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2014-08-19+150,000→ 150,000 total

Companies

Recent Filings

Address

C/O 400 DEXTER AVENUE NORTH SUITE 1200

SEATTLE, WA, 98109

View on SEC.gov